Berlex Laboratories has signed a four-year agreement to supply New York Medical Imaging with Ultravist, an x-ray diagnostic contrast agent. The contract has a projected value of more than $6 million in
Berlex Laboratories has signed a four-year agreement to supply New York Medical Imaging with Ultravist, an x-ray diagnostic contrast agent. The contract has a projected value of more than $6 million in sales.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.